X0206 3/A 2017-07-12 2021-04-22 0 0001653821 CEN BIOTECH INC CENBF 0001737899 Aubrey de Lavenu Harold Andre 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 Common Stock 13321 D Convertible Note 1.6000 2016-05-24 Common Stock 62500 D Convertible Note 1.6000 2016-11-25 Common Stock 125000 D Convertible Note 1.6000 2016-12-14 Common Stock 156250 D Convertible Note 1.6000 2017-02-09 Common Stock 312500 D Harold Aubrey de Lavenu (the "Reporting Person") was appointed to his position with CEN Biotech, Inc. (the "Issuer") on July 12, 2017 and owned 13,321 shares of the Issuer's common stock on such date. On April 2, 2021, the Issuer appointed the Reporting Person to serve as a Vice President of the Issuer effective as of April 2, 2021 Additionally the Reporting Person owned convertible notes on July 12, 2017, which the Reporting Person purchased from the Issuer which were at such time and still are convertible into 656,250 shares of the Issuer's common stock. The convertible notes included in this table matured on May 12, 2018, November 25, 2018, December 14, 2018, and February 19, 2019, respectively, (the "Maturity Dates"), however, the ability to convert the notes into shares did not expire on the Maturity Dates of the notes. /s/ Harold Aubrey de Lavenu 2021-05-28